background
suggest
differ
hepat
b
viru
hbv
genotyp
may
distinct
virolog
characterist
correl
clinic
outcom
antivir
therapi
natur
cours
infect
hydrodynam
inject
hi
hbv
mous
model
use
tool
studi
hbv
replic
vivo
howev
hbv
genotyp
use
studi
hi
method
construct
replicationcompet
clone
contain
fold
overlength
hbv
genotyp
b
genom
test
vitro
vivo
moreov
hbv
genotyp
b
clone
base
paavmc
vector
construct
fold
hbv
genom
result
plasmid
b
test
hi
mice
applic
sirna
hbx
gene
test
hbv
genotyp
b
hi
mous
model
result
fold
hbv
clone
show
higher
replic
gene
express
fold
hbv
clone
compar
genotyp
mice
hi
b
show
higher
hbsag
hbeag
express
well
hbv
dna
replic
level
higher
clearanc
rate
applic
two
plasmid
express
smallshort
interf
rna
sirna
hbx
gene
hbv
genotyp
b
hi
mous
model
lead
inhibit
hbv
gene
express
replic
howev
hbv
gene
express
may
resum
mice
despit
initi
delay
suggest
transient
suppress
hbv
replic
sirna
may
insuffici
prevent
viral
spread
particularli
gene
silenc
highli
effect
conclus
taken
togeth
hi
mous
model
hbv
genotyp
b
genom
success
establish
show
differ
characterist
vivo
compar
genotyp
genom
effect
gene
silenc
hbx
gene
determin
whether
hbv
replic
may
sustain
inhibit
sirna
vivo
hepat
b
viru
hbv
caus
acut
chronic
infect
human
liver
subsequ
hepat
cirrhosi
hepatocellular
carcinoma
hcc
sever
affect
human
health
although
highli
effect
vaccin
avail
prevent
new
hbv
infect
million
peopl
worldwid
alreadi
chronic
infect
suffer
chronic
liver
injuri
immunolog
wellcharacter
small
anim
model
hbv
infect
remain
unavail
due
strict
host
specif
hbv
infect
greatli
hamper
hbvrelat
research
laboratori
mous
genet
immunolog
defin
larg
collect
genet
modifi
anim
exist
howev
mice
infect
hbv
sever
line
transgen
mice
replic
compet
hbv
genom
establish
repres
power
tool
hbv
research
howev
hbv
replic
transgen
mice
gener
integr
hbv
sequenc
harbor
hepatocyt
differ
occur
natur
infect
presenc
hbv
genom
mous
line
inevit
induc
immun
toler
hbv
antigen
addit
capabl
product
transgen
mous
model
readili
avail
ordinari
laboratori
condit
transplant
mous
model
establish
use
differ
studi
howev
model
base
immunodefici
mous
strain
difficult
handl
laboratori
hydrodynam
inject
hi
replicationcompet
hbv
dna
tail
vein
mice
establish
hbv
replic
mous
liver
inject
mice
persist
hbv
surfac
antigenemia
hbsag
greater
month
hbv
persist
determin
mous
genet
background
plasmid
backbon
hbv
hi
mous
model
highli
interest
model
test
vaccin
strategi
mechan
viral
persist
model
may
use
studi
replic
compet
hbv
construct
previous
establish
hbv
hi
mous
model
base
hbv
genotyp
replicationcompet
clone
hbv
genotyp
b
c
highli
preval
asia
may
distinct
virolog
characterist
correl
clinic
outcom
natur
cours
infect
antivir
therapi
warrant
establish
hbv
hi
mous
model
character
hbv
strain
patient
chronic
hbv
infect
current
treat
interferon
alpha
nucleotid
analog
entecavir
tenofovir
howev
current
therapi
limit
success
rate
frequent
viral
recurr
cessat
therapi
therefor
new
antivir
strategi
requir
rna
interfer
develop
potenti
therapeut
approach
previou
studi
sirna
target
differ
region
hbv
genom
use
hbx
gene
encod
small
nonstructur
protein
divers
function
requir
hbv
effici
replic
hbx
mrna
contain
common
sequenc
four
transcript
hbv
make
potenti
use
target
antivir
therapi
studi
address
question
whether
replic
compet
hbv
genotyp
b
clone
could
replic
transient
persist
hi
mous
model
plasmid
nonvir
vector
retrovir
vector
express
sirna
target
hbx
gene
construct
use
construct
ask
gene
silenc
hbx
sirna
genotyp
b
influenc
cours
hbv
replic
persist
hi
mous
model
fold
overlength
hbv
genom
dna
includ
nt
nt
nt
clone
pbluesript
ii
ks
vector
separ
construct
procedur
shown
addit
file
figur
schemat
represent
fold
hbv
genom
shown
addit
file
figur
plasmid
analyz
restrict
enzym
digest
psti
saci
psti
saci
restrict
digest
b
b
b
result
appear
addit
band
kb
addit
pbluescript
ii
ks
vector
respect
addit
file
figur
consist
psti
restrict
digest
b
b
b
confirm
vector
size
kb
respect
addit
file
figur
hbv
fold
length
genom
dna
amplifi
subclon
noti
site
paavmc
vector
agil
technolog
la
jolla
usa
construct
procedur
b
shown
addit
file
figur
plasmid
b
identifi
noti
restrict
digest
addit
band
kb
data
shown
investig
function
b
b
b
hepatoma
cell
plasmid
transfect
cell
h
posttransfect
cultur
supernat
transfect
cell
harvest
subject
hbsag
hbeag
detect
shown
figur
hbsag
hbeag
level
cultur
supernat
b
transfect
cell
significantli
higher
b
b
plasmid
p
compar
replic
compet
b
b
b
vivo
balbc
mice
subject
hi
plasmid
group
contain
mice
dpi
mous
serum
sampl
collect
hbv
dna
quantif
liver
tissu
collect
immunohistochem
stain
hbcag
figur
show
hi
b
result
significantli
higher
hbv
dna
level
mous
serum
sampl
compar
hi
b
b
p
immunostain
hbcag
demonstr
hbcag
posit
hepatocyt
could
detect
mous
liver
hi
three
plasmid
absent
control
mice
moreov
hbcag
posit
hepatocyt
abund
mous
liver
b
transfect
mice
figur
report
hbv
persist
hi
mice
depend
host
genet
background
plasmid
backbon
firstli
fold
overlength
hbv
genom
clone
paav
vector
gener
b
hi
b
perform
mice
examin
whether
hbv
isol
genotyp
b
abl
establish
persist
replic
vivo
parallel
describ
huang
et
al
use
refer
b
group
includ
mice
group
includ
mice
serum
hbv
dna
level
mice
b
determin
indic
time
point
week
higher
mice
figur
liver
tissu
collect
mice
inject
b
dpi
dpi
dpi
dpi
hbv
dna
extract
liver
tissu
sampl
assay
hbv
dna
southern
blot
analysi
band
correspond
expect
size
input
hbv
plasmid
hbv
replic
intermedi
includ
relax
circular
rc
singlestrand
ss
hbv
dna
could
detect
liver
hbsagposit
mice
hydrodynam
inject
b
figur
hbv
replic
intermedi
higher
level
mice
inject
b
intrahepat
hbv
dna
level
also
detect
realtim
pcr
result
consist
southernblot
result
figur
immunohistochem
stain
liver
section
hbcag
reveal
cytoplasm
nucleic
hbcag
detect
liver
hbsagposit
mice
hydrodynam
inject
b
figur
contrast
hbcag
posit
cell
present
liver
control
mice
hbsagneg
mice
result
obtain
experi
indic
hbv
genotyp
b
construct
replic
compet
mous
liver
investig
whether
vector
backbon
host
genet
background
also
influenc
persist
hbv
isol
genotyp
b
b
b
plasmid
inject
hydrodynam
tail
vein
male
balbc
mice
group
includ
mice
hi
mice
regularli
bled
tempor
chang
hbsag
hbeag
hbcab
hbsab
hbv
dna
level
monitor
balbc
mice
inject
b
hbsag
level
increas
first
three
day
drop
quickli
afterward
mice
becam
neg
wpi
howev
hbsag
level
balbc
mice
inject
b
declin
slowli
time
mice
hbsag
posit
day
dpi
hbsag
becam
undetect
mice
wpi
figur
contrast
balbc
mice
hbsag
level
decreas
much
slowli
inject
plasmid
mice
mice
inject
b
hbsagposit
wpi
mice
becam
neg
wpi
moreov
mice
inject
b
still
hbsagposit
wpi
hbsag
remain
detect
mice
week
figur
result
confirm
host
genet
background
well
vector
backbon
influenc
hbv
persist
addit
also
compar
kinet
viremia
b
hi
mous
model
serum
hbv
dna
level
b
inject
mice
higher
inject
mice
figur
howev
mice
receiv
b
lower
posit
rate
hbsag
compar
receiv
mice
hbsag
posit
week
hi
b
half
mice
inject
figur
none
mice
inject
produc
hbsab
dpi
although
produc
hbcab
day
tabl
howev
mice
receiv
b
produc
hbsab
dpi
moreov
rais
hbsab
b
inject
mice
faster
shown
tabl
mice
produc
hbsab
hbsag
neg
mice
develop
hbcab
dpi
thu
differ
replic
compet
hbv
genom
aav
vector
may
differ
abil
establish
persist
replic
mice
impair
hbcag
specif
cellular
immun
b
inject
mice
initi
activ
huang
et
al
confirm
toler
toward
hbv
surfac
antigen
model
due
insuffici
cellular
immun
hepat
b
core
antigen
confirm
result
hbvspecif
ctl
respons
full
length
hbcag
peptid
detect
dpi
hi
elispot
assay
produc
cell
dpi
almost
could
detect
signific
level
hbcag
specif
cell
splenocyt
figur
howev
averag
number
secret
cell
splenocyt
b
inject
mice
respect
figur
signific
differ
two
group
p
result
indic
hbcagspecif
immun
respons
may
play
key
role
clear
hbv
infect
earli
stage
hi
mous
model
appli
rnai
vivo
vector
base
express
sirna
explor
hi
mous
model
antivir
effect
investig
vitro
shown
figur
hbsag
hbeag
level
decreas
b
cotransfect
cell
respect
howev
b
cotransfect
cell
hbsag
hbeag
level
inhibit
respect
differ
concentr
use
test
whether
antivir
effect
dosedepend
figur
c
show
inhibit
hbsag
hbeag
express
well
hbv
dna
concentrationdepend
manner
rang
dose
effect
reduct
hbsag
hbeag
hbv
dna
transient
transfect
compar
antivir
effect
vitro
b
differ
concentr
cotransfect
cell
figur
show
inhibit
hbsag
hbeag
dosedepend
manner
howev
signific
differ
antivir
effect
p
reduc
serum
hbsag
hbv
dna
level
mice
hi
base
previou
experi
b
coinject
mice
determin
antivir
effect
vivo
group
contain
mice
initi
hbsag
level
mice
significantli
reduc
hi
presenc
plasmid
dpi
p
compar
control
group
receiv
empti
vector
figur
howev
hbsag
level
treat
mice
quickli
increas
follow
reach
level
control
dpi
contrast
hbsag
level
treat
mice
inhibit
significantli
lower
degre
dpi
compar
control
group
p
hbsag
becam
detect
mice
dpi
worthi
note
major
mice
receiv
hbsag
neg
whole
experiment
period
tabl
hbv
dna
concentr
mous
sera
determin
well
correl
hbsag
level
figur
figur
show
hbsag
posit
rate
treat
mice
significantli
decreas
comparison
control
dpi
thereaft
posit
rate
hbsag
treat
mice
increas
gradual
show
signific
differ
comparison
control
dpi
posit
rate
hbsag
treat
mice
remain
lower
level
group
week
post
inject
wpi
show
similar
level
group
wpi
consist
immunostain
hbcag
liver
section
mice
hi
demonstr
coapplic
abolish
hbcag
express
mous
liver
dpi
figur
howev
hbcag
may
becom
detect
mous
liver
receiv
similar
control
mice
week
hi
result
indic
could
significantli
inhibit
hbsag
product
hbv
replic
howev
vector
effici
reduc
hbsag
hbv
dna
level
present
studi
hbv
genotyp
b
hi
mous
model
establish
hi
b
hbsag
hbv
dna
detect
peripher
blood
southern
blot
immunohistochem
stain
analysi
reveal
hbv
dna
hbcag
detect
liver
tissu
hbsagposit
mice
differ
hepat
b
viru
genotyp
may
distinct
virolog
characterist
may
correl
antivir
cur
effect
clinic
outcom
major
hbv
infect
distribut
asiapacif
region
region
patient
mainli
infect
genotyp
b
c
previou
studi
show
china
taiwan
approxim
patient
thirtyf
year
old
infect
hbv
would
develop
hcc
carri
hbv
genotyp
b
infect
system
hand
examin
replic
hbv
genotyp
b
clone
mous
model
present
studi
investig
effect
hbv
genom
length
hbv
replic
compet
find
optim
structur
replic
compet
hbv
genotyp
b
clone
three
clone
figur
increas
length
fold
length
hbv
genom
improv
replic
compet
nevertheless
replic
compet
declin
could
reach
origin
level
hbv
natur
infect
state
length
less
fold
hbv
genom
durantel
et
al
group
use
fold
length
hbv
genom
studi
drug
resist
hbv
isol
howev
ad
strong
foreign
promot
enhanc
hbv
transcript
replic
conclus
fold
hbv
genom
length
contain
complet
extra
copi
entir
enhi
enhii
hbx
gene
describ
present
studi
could
regard
optim
length
hbv
replic
construct
authent
hbv
sequenc
independ
foreign
promot
establish
persist
replic
hbv
mous
model
hbv
genotyp
b
clone
fold
length
hbv
genotyp
b
genom
subclon
paavmc
vector
introduc
mice
hi
huang
et
al
found
aav
vector
contribut
persist
hbv
mous
liver
therefor
use
similar
vector
paavmc
construct
hbv
genotyp
b
replic
clone
studi
vector
also
itr
invert
termin
repeat
structur
consid
key
factor
stabl
exist
vivo
integr
nonintegr
way
vector
express
protein
except
encod
target
gene
vector
backbon
direct
effect
immun
system
number
mice
group
posit
antihbc
antihb
antibodi
inject
hydrodynam
b
plasmid
mice
hbsab
hbsag
neg
hi
mice
present
higher
hbv
dna
level
lower
posit
rate
hbsag
serum
compar
inject
mice
appar
hbv
replic
strictli
correl
hbsag
product
known
patient
result
indic
model
robust
genotyp
use
compar
b
huang
et
al
confirm
toler
toward
hbv
surfac
antigen
model
due
insuffici
cellular
immun
hepat
b
core
antigen
document
human
repeat
experi
obtain
result
figur
b
differ
plasmid
backbon
clone
need
investig
antigenemia
product
hbv
particl
highli
reproduc
persist
hbv
replic
mous
model
base
hi
make
model
appropri
evalu
efficaci
antivir
drug
therefor
investig
antivir
effect
vectorexpress
hbx
sirna
model
coapplic
hbx
sirna
express
plasmid
treatment
mice
induc
signific
inhibit
hbv
replic
express
b
coinject
tail
vein
mice
either
hbv
express
replic
effici
inhibit
two
method
commonli
use
silenc
target
gene
chemic
synthes
sirna
good
specif
commonli
use
cell
transfect
howev
sirna
chemic
modifi
instabl
elimin
rapidli
vitro
vivo
product
sirna
particularli
specif
chemic
modif
expens
anoth
approach
use
sirna
transcript
vector
disadvantag
use
retrovir
vector
exampl
lower
transfect
effici
slow
action
compar
chemic
synthes
sirna
howev
vectorbas
approach
advantag
regard
stabil
cost
import
prolong
express
sirna
maintain
inhibit
hbv
moreov
psuper
retro
vector
transfect
packag
cell
line
cell
line
could
produc
retrovir
supernat
obtain
higher
rate
stabl
cell
integr
manual
psuper
rnai
system
oligoengin
washington
usa
hi
nake
plasmid
dna
simpl
yet
effect
vivo
gene
deliveri
method
hepatocyt
earli
report
suggest
larg
portion
hepatocyt
could
reach
techniqu
therefor
could
use
method
test
efficaci
rnai
base
antivir
therapi
mous
model
certainli
still
challeng
transfer
knowledg
gain
system
human
situat
studi
nonvir
psuperbas
retrovir
vector
psuperretro
use
construct
shrna
small
hairpin
rna
express
plasmid
target
hbx
gene
hbv
psuperretro
vector
contain
promot
rna
polymeras
iii
like
promot
transcript
shrna
steadili
show
persist
inhibitori
effect
vitro
psuperretro
vector
includ
termin
ltr
structur
murin
stem
cell
viru
psuperretro
vector
transfect
packag
cell
line
produc
retrovir
supernat
obtain
higher
rate
stabl
cell
integr
addit
vector
contain
incomplet
packag
signal
could
produc
recombin
retrovirus
manual
psuper
rnai
system
oligoengin
washington
usa
psuperbas
figur
specif
tcell
respons
hbcag
epitop
mice
hi
specif
tcell
respons
full
length
hbcag
peptid
hi
number
hbcag
specif
secret
cell
splenocyt
b
inject
mice
b
elispot
assay
presenc
full
length
hbcag
peptid
experi
done
duplic
data
analyz
test
signific
differ
two
group
p
puc
origin
vector
manual
psuper
rnai
system
oligoengin
washington
usa
use
compar
stabil
psuperretro
vivo
differ
vector
gene
silenc
effect
like
due
stabil
vivo
hbx
protein
play
import
role
hbv
replic
hbv
induc
hcc
therefor
hbx
becam
good
target
gene
gene
silenc
recent
year
importantli
hbv
rna
transcript
share
sequenc
hbx
due
uniqu
transcript
mechan
sirna
target
hbx
region
actual
knock
hbv
rna
shown
previou
studi
result
show
sirna
target
region
nt
hbx
code
region
stronger
antivir
effect
target
region
nt
known
sirnaspecif
featur
low
gc
content
bia
toward
low
intern
stabil
sens
strand
lack
invert
repeat
sens
strand
base
prefer
interact
cellular
machineri
call
risc
like
contribut
effici
rnai
process
rel
influenc
paramet
fulli
understood
investig
mani
group
b
coinject
tail
vein
mice
hbv
express
replic
could
significantli
inhibit
first
week
thereaft
antivir
effect
declin
treat
mice
wherea
antivir
effect
maintain
least
week
result
indic
retrovir
vector
base
hbx
sirna
express
plasmid
could
much
effect
inhibit
hbv
express
replic
nonvir
vector
base
hbx
sirna
express
plasmid
among
mice
receiv
hbv
replic
complet
suppress
major
mice
hbsag
detect
whole
experiment
period
week
howev
hbv
gene
express
replic
may
resum
mice
despit
initi
delay
indic
transient
suppress
hbv
replic
hbx
sirna
may
also
fail
clear
hbv
complet
individu
worth
mention
chang
serum
hbsag
hbv
dna
mice
applic
hbx
sirna
occur
differ
kinet
reason
may
differ
requir
hbsag
translat
hbv
dna
replic
well
establish
small
fraction
hbsag
requir
virion
product
patient
chronic
hbv
infect
hbv
dna
load
correl
hbsag
result
suggest
measur
prolong
antivir
effect
sirna
investig
futur
studi
summari
establish
hbv
genotyp
b
hi
mous
model
reliabl
could
appli
studi
genet
antivir
research
chronic
hbv
infect
retrovir
vector
base
hbx
sirna
express
plasmid
could
effici
inhibit
hbv
express
replic
suggest
sirnabas
treatment
strategi
may
addit
therapeut
option
futur
clinic
use
patient
chronic
hbv
infect
plasmid
contain
valu
hbv
dna
mean
copi
number
hbv
dna
lower
detect
limit
data
analyz
oneway
anova
differ
statist
signific
p
group
vs
psrhbxicon
group
p
group
vs
group
oneway
anova
immunohistochem
stain
hbcag
hepatocyt
mice
treat
psrhbxicon
psr
vector
separ
day
post
inject
mice
treat
psrhbxicon
wpi
origin
magnif
replic
compet
overlength
hbv
genom
vivo
test
hi
b
b
b
plasmid
balbc
mice
femal
week
old
breed
coloni
experiment
anim
center
hubei
provinc
china
mice
per
group
mice
male
week
old
breed
coloni
experiment
anim
center
shanghai
china
subject
hi
b
test
abil
plasmid
establish
persist
hbv
replic
b
group
includ
mice
group
includ
mice
investig
factor
affect
hbv
persist
mous
liver
inject
b
b
balbc
mice
separ
mice
per
group
hi
experi
carri
describ
previous
quantif
hbv
dna
perform
use
routin
real
time
pcr
procedur
describ
previous
hbv
copi
number
determin
sybr
green
real
time
pcr
master
mix
commerci
avail
assay
kit
toyobo
osaka
japan
melt
curv
analysi
agaros
gel
electrophoresi
use
verifi
specif
realtim
pcr
follow
primer
use
forward
primer
cat
cct
gct
gct
nt
revers
primer
tga
aca
aat
ggc
nt
accord
refer
sequenc
genbank
access
number
serum
contain
known
concentr
hbv
dna
use
posit
control
liver
tissu
taken
mice
receiv
hi
b
b
b
day
post
inject
dpi
mice
receiv
hi
b
dpi
dpi
dpi
dpi
dpi
dpi
use
immunohistochem
stain
hbcag
hepatocyt
liver
tissu
mice
receiv
nacl
use
neg
control
liver
tissu
collect
mice
embed
paraffin
intrahepat
hbcag
visual
immunohistochem
stain
rabbit
antihbc
dako
liver
tissu
section
liver
tissu
section
also
stain
hematoxylin
purif
southern
blot
analysi
hbv
dna
liver
tissu
mice
total
dna
b
hbx
sirna
express
plasmid
cotransfect
cell
liver
tissu
mice
isol
use
commerci
kit
omega
norcross
usa
isol
hbv
dna
subject
agaros
gel
electrophoresi
follow
denatur
southern
blot
analysi
dna
sampl
treat
rnase
gel
electrophoresi
hbv
dna
detect
hybrid
digoxigenin
dig
roch
lew
uk
label
full
length
hbv
probe
hybrid
signal
visual
xray
film
use
alkalin
phosphataseantidigfab
conjug
presenc
chemiluminesc
substrat
cdpstar
roch
elispot
assay
carri
use
mous
precoat
elispot
kit
dakew
shenzhen
china
restrict
site
shown
ital
gene
sequenc
includ
primer
indic
underl
genbank
access
number
use
refer
sequenc
given
accord
manufactur
instruct
briefli
flatbottom
microtit
plate
preincub
coat
antibodi
monoclon
antibodi
overnight
block
hr
mous
splenocyt
densiti
cell
per
well
ad
well
triplic
final
concentr
full
length
hbcag
peptid
prospec
nessziona
israel
separ
incub
co
hr
cona
sigma
st
loui
usa
use
posit
control
thereaft
cell
remov
well
wash
ten
time
pb
contain
pbst
incub
ml
biotinyl
antibodi
hr
plate
wash
pbst
incub
ml
hrpstreptoavidin
solut
hr
spotform
cell
count
analyz
elispot
plate
reader
bioread
biosi
germani
result
present
spotform
cell
per
cell
complementari
sequenc
phosphoryl
ligat
bglii
hindiii
digest
psuperbas
psuperretro
vector
result
plasmid
name
psbhbxicon
psrhbxicon
clone
sequenc
confirm
correct
sequenc
data
evalu
student
ttest
oneway
anova
follow
tukey
post
hoc
test
statist
signific
data
consid
p
